HARTFORD HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $29.1M
- Transactions
- 2,967
- Companies
- 40
- Average per transaction
- $9,810
Who reported the payments
| Medtronic | $5,815,647 |
| Intuitive Surgical | $3,030,143 |
| Merck | $2,433,800 |
| Covidien LP | $2,117,133 |
| Shionogi Inc | $1,240,807 |
| AbbVie | $1,047,950 |
| Amgen | $933,588 |
| Edwards Lifesciences | $877,975 |
| Novartis | $757,873 |
| Siemens Medical Solutions USA, Inc. | $545,573 |
| Boston Scientific | $501,349 |
| Genentech, Inc. | $477,386 |
| AstraZeneca | $452,718 |
| Pfizer | $423,095 |
| Paratek Pharmaceuticals, Inc. | $419,312 |
| Lilly USA, LLC | $406,000 |
| Boehringer Ingelheim | $378,640 |
| F. Hoffmann-la Roche AG | $369,041 |
| La Jolla Pharmaceutical Company | $359,509 |
| GSK | $352,801 |
| Janssen Research & Development, LLC | $343,787 |
| Novocure GmbH | $290,388 |
| E.r. Squibb & Sons, L.L.C. | $277,341 |
| Livanova USA, Inc. | $249,191 |
| Abbott | $233,289 |
| Medical Device Business Services, Inc. | $214,636 |
| Globus Medical | $212,866 |
| Acutus Medical, Inc. | $199,639 |
| Bristol Myers Squibb | $167,788 |
| Melinta Therapeutics, LLC | $149,063 |
| Stryker | $147,457 |
| Biosense Webster, Inc. | $133,094 |
| Takeda Pharmaceuticals U.S.A., Inc. | $132,886 |
| Portola Pharmaceuticals, LLC | $132,500 |
| Baxter Healthcare | $131,501 |
| Endotronix, Inc. | $130,338 |
| Philips North America LLC | $111,955 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $109,110 |
| Microvention, Inc. | $100,000 |
| Cumberland Pharmaceuticals, Inc. | $95,932 |